A research team from POSTECH has developed a biodegradable polymer-based delivery system that efficiently transports mRNA. The study was recently published in Biomaterials.
Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT), a commercial-stage biotechnology company with a market capitalization of $428 million specializing in mRNA therapeutics and vaccines, stands at a ...
A US-based pharmaceutical company known for its revolutionary mRNA technology, has completed construction of its Moderna Innovation and Technology Centre (MITC) at Harwell in Oxfordshire.
In a groundbreaking announcement, former President Donald Trump has unveiled an ambitious $500 billion plan aimed at pioneering a cancer vaccine that could change the landscape of treatment for ...
The same mRNA technology behind COVID-19 vaccines is now being used in the fight against cancer, and the Markey Cancer Center is among an elite group of ...